Health Canada has announced the labeling update for all cholesterol-lowering drugs (statins). The update warns about the risk of increased blood sugar levels and an increased risk of diabetes among patients with pre-existing risk factors ...
Health Canada will inform Canadians of a labeling update for all cholesterol-lowering drugs, which are also known as statins, regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients who are ...
Tags: drug labels, Healthcare, statins
Biopharmaceutical company AstraZeneca has announced agreement with the US Food and Drug Administration (FDA) with regard to FASLODEX (fulvestrant) Injection label changes. The labeling update includes results and a Kaplan-Meier plot of ...
Tags: FASLODEX Injection label, AstraZeneca, prescription medicines
US Food and Drug Administration (FDA) has approved an update to the labeling for Bristol-Myers Squibb's Baraclude to include data on African Americans and liver transplant recipients with chronic hepatitis B infection. The present ...